Triple-negative breast cancer: Early assessment with 18F-FDG PET/CT during neoadjuvant chemotherapy identifies patients who are unlikely to achieve a pathological complete response

被引：0
|
作者：
Groheux, David [1 ]
Hindie, Elif [1 ]
Giacchetti, Sylvie [2 ]
Delord, Marc [3 ]
Hamy, Anne-Sophie [2 ]
De-roquancourt, Anne [4 ]
Vercellino, Laetitia [1 ]
Berenger, Nathalie [1 ]
Marty, Michel [2 ]
Espie, Marc [2 ]
机构：
[1] St Louis Hosp, Dept Nucl Med, Paris, France
[2] St Louis Hosp, Breast Dis Unit, Paris, France
[3] Inst Univ Hematol, Plateforme Bioinformat Biostat, Paris, France
[4] St Louis Hosp, Dept Pathol, Paris, France
来源：
JOURNAL OF NUCLEAR MEDICINE | 2011年 / 52卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
366
引用
收藏
页数：2
相关论文
共 50 条
  • [21] The role of 18F-FDG PET/CT in evaluation of early response to neoadjuvant chemotherapy in patients with locally advanced breast cancer
    Kumar, Amandeep
    Kumar, Rakesh
    Seenu, Vathalaru
    Gupta, Sidharatha Datta
    Chawla, Madhavi
    Malhotra, Arun
    Mehta, Sada Nand
    EUROPEAN RADIOLOGY, 2009, 19 (06) : 1347 - 1357
  • [22] The role of 18F-FDG PET/CT in evaluation of early response to neoadjuvant chemotherapy in patients with locally advanced breast cancer
    Amandeep Kumar
    Rakesh Kumar
    Vathalaru Seenu
    Sidharatha Datta Gupta
    Madhavi Chawla
    Arun Malhotra
    Sada Nand Mehta
    European Radiology, 2009, 19 : 1347 - 1357
  • [23] On the usefulness of the 18F-FDG PET radiome of triple negative breast tumor to predict response to neoadjuvant chemotherapy
    Boughdad, Sarah
    Orlhac, Fanny
    Nioche, Christophe
    Dirand, Anne-Sophie
    Champion, Laurence
    Buvat, Irene
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60
  • [24] Clinical utility of [18F]FDG PET/CT in triple-negative breast cancer patients treated with neoadjuvant chemotherapy with or without immunotherapy
    Seban, R.
    Arnaud, E.
    Loirat, D.
    Cabel, L.
    Cottu, P.
    Djerroudi, L.
    Hescot, S.
    Loap, P.
    Bonneau, C.
    Bidard, F.
    Huchet, V.
    Jehanno, N.
    Berenbaum, A.
    Champion, L.
    Buvat, I.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S33 - S33
  • [25] Early monitoring of response to neoadjuvant chemotherapy in breast cancer with 18F-FDG PET/CT: defining a clinical aim
    David Groheux
    Sylvie Giacchetti
    Marc Espié
    Domenico Rubello
    Jean-luc Moretti
    Elif Hindié
    European Journal of Nuclear Medicine and Molecular Imaging, 2011, 38 : 419 - 425
  • [26] Early monitoring of response to neoadjuvant chemotherapy in breast cancer with 18F-FDG PET/CT: defining a clinical aim
    Groheux, David
    Giacchetti, Sylvie
    Espie, Marc
    Rubello, Domenico
    Moretti, Jean-luc
    Hindie, Elif
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 (03) : 419 - 425
  • [27] Clinical predictors of pathological complete response to neoadjuvant chemotherapy in triple-negative breast cancer
    Nakashoji, Ayako
    Matsui, Akira
    Nagayama, Aiko
    Iwata, Yuko
    Sasahara, Manami
    Murata, Yuya
    ONCOLOGY LETTERS, 2017, 14 (04) : 4135 - 4141
  • [28] The role of basal metabolic and volumetric 18F-FDG PET/CT 18 parameters and their changes in predicting pathological complete response in breast cancer patients receiving neoadjuvant chemotherapy
    Kepenek, Ferat
    Karaoglan, Huseyin
    Can, Canan
    Komek, Halil
    Kaplan, Ihsan
    Etem, Hulya
    Ebinc, Senar
    Kavak, Seyhmus
    Gundogan, Cihan
    HELLENIC JOURNAL OF NUCLEAR MEDICINE, 2022, 25 (03) : 235 - 246
  • [29] Prediction of pathological complete response to neoadjuvant chemotherapy in locally advanced breast cancer by using a deep learning model with 18F-FDG PET/CT
    Bulut, Gulcan
    Atilgan, Hasan Ikbal
    Cinarer, Gokalp
    Kilic, Kazim
    Yikar, Deniz
    Parlar, Tuba
    PLOS ONE, 2023, 18 (09):
  • [30] 18F-FDG PET/CT to Predict Response to Neoadjuvant Chemotherapy and Prognosis in Inflammatory Breast Cancer
    Champion, Laurence
    Lerebours, Florence
    Alberini, Jean-Louis
    Fourme, Emmanuelle
    Gontier, Eric
    Bertrand, Francoise
    Wartski, Myriam
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (09) : 1315 - 1321
12345